Antiparasitic Activity of Compounds Isolated from Ganoderma tuberculosum (Agaricomycetes) from Mexico.

The genus Ganoderma has a long history of use in traditional Asiatic medicine due to its different nutritional and medicinal properties. In Mexico, the species G. tuberculosum is used in indigenous communities, for example, the Wixaritari and mestizos of Villa Guerrero Jalisco for the treatment of diseases that may be related to parasitic infections; however, few chemical studies corroborate its traditional medicinal potential. Thereby, the objective of this study was to isolate and identify anti-parasitic activity compounds from a strain of G. tuberculosum native to Mexico. From the fruiting bodies of G. tuberculosum (GVL-21) a hexane extract was obtained which was subjected to guided fractioning to isolate pure compounds. The in vitro anti-parasitic activity of the pure compound (IC50) was assayed against Leishmania amazonensis, Trypanosoma cruzi, Acanthamoeba castellanii Neff, and Naegleria fowleri. Furthermore, the cytotoxicity (CC50) of the isolated compounds was determined against murine macrophages. The guided fractioning produced 5 compounds: ergosterol (1), ergosta-4,6,8(14),22-tetraen-3-one (2), ergosta-7,22-dien-3ß-ol (3), 3,5-dihydroxy-ergosta-7,22-dien-6-one (4), and ganoderic acid DM (5). Compounds 2 and 5 showed the best anti-parasitic activity in an IC50 range of 54.34 ± 8.02 to 12.38 ± 2.72 µM against all the parasites assayed and low cytotoxicity against murine macrophages. The present study showed for the first time the in vitro anti-parasitic activity of compounds 1-5 against L. amazonensis, T. cruzi, A. castellanii Neff, and N. fowleri, corroborating the medicinal potential of Ganoderma and its traditional applications.

Biological Activities of Different Strains of the Genus Ganoderma spp. (Agaricomycetes) from Mexico.

Antiproliferative, antioxidant, and antibacterial activities were determined for 14 extracts obtained with a mixture of chloroform-methanol (1:1) from the mycelial cultures of 14 wild strains of the genus Ganoderma collected in the central-south part of Veracruz Province, Mexico. Identification of the strains collected was confirmed based on rDNA internal transcribed spacer phylogenetic analysis. The strains G. tuberculosum (GVL-04 and GVL-21), G. tornatum (GVL-05), and G. weberianum (GVL-17 and GVL-26) manifested activity in at least one of the six cancer cell lines tested (HBL-100 and T-47D [breast], HeLa [cervix], A-549 and SW1573 [lung], and WiDr [colon]), with a minimum concentration necessary to cause 50% growth inhibition of cancer cells (GI50) < 50 µg/mL-1. The strains G. tuberculosum (GVL-21) and G. martinicense (GVL-35) had the best antioxidant activity, with values of 62.5 ± 3.9 and 40 ± 2.0 µM Trolox equivalents/mg according to the 1,1-diphenyl-2-picrihydrazyl assay. In addition, nine extracts demonstrated antibacterial activity against Clavibacter michiganensis in a concentration range of 31.5 to 1000 µg/mL. Although these results were expected due to the bioactive potential of Ganoderma species, the antibacterial activity against C. michiganensis causing tomato canker is highlighted.